Tromantadine is an antiviral drug used for the treatment of herpes simplex virus (HSV) infections; it inhibits the replication of herpes simplex virus type 1 (HSV-1) and HSV-2; it is formulated as a gel under the brand names Viru-Merz and Viru-Merz Serol; its antiviral activity is comparable to that of acyclovir; it reduces herpes simplex virus-induced cytopathic effect and virus production in vitro; it inhibits viral and viral polypeptide synthesis when added at the time of infection or 4 hours post-infection; it acts similarly to cyclosporin A by inhibiting virus-induced cell-cell fusion.